Emergent Biosolutions stock forecast
Emergent Biosolutions (ER4) Stock Forecast & Price Target
ER4 Analyst Ratings
ER4 Stock 12 Month Forecast
Average Price Target
CHF 8.14▲(69.46% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ram Selvaraju | H.C. Wainwright | CHF 8.14 | buy | 69.46%Upside | Reiterated | 09/09/26 | ||
| Jessica Fye | J.P. Morgan | ― | sell | ― | Initiated | 08/21/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ram SelvarajuH.C. Wainwright | BuyReiteratedCHF 8.14 | 09/09/26 | 69.46%Upside | ||
| Jessica FyeJ.P. Morgan | SellInitiated | 08/21/26 | ― |
Best Analysts Covering Emergent Biosolutions
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.39% per trade.
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -18.01% per trade.
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 21.43% of your transactions generating a profit, with an average return of -20.81% per trade.
ER4 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 1 |
| Buy | 2 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 3 | 3 | 3 | 1 |
In the current month, ER4 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ER4 average Analyst price target in the past 3 months is 8.14.
ER4 Financial Forecast
ER4 Earnings Forecast
Next quarter’s earnings estimate for ER4 is -CHF 0.14 with a range of -CHF 0.18 to -CHF 0.09. The previous quarter’s EPS was -CHF 0.30. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ER4 Sales Forecast
Next quarter’s sales forecast for ER4 is CHF 113.50M with a range of CHF 104.00M to CHF 125.06M. The previous quarter’s sales results were CHF 90.80M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
